{"pmid":32441243,"title":"Clostridiodes difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.","text":["Clostridiodes difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.","We describe 9 patients at a medical center in Detroit, Michigan, USA, with severe acute respiratory syndrome coronavirus 2 and Clostridiodes difficile. Both infections can manifest as digestive symptoms and merit screening when assessing patients with diarrhea during the coronavirus disease pandemic. These co-infections also highlight the continued importance of antimicrobial stewardship.","Emerg Infect Dis","Sandhu, Avnish","Tillotson, Glenn","Polistico, Jordan","Salimnia, Hossein","Cranis, Mara","Moshos, Judy","Cullen, Lori","Jabbo, Lavina","Diebel, Lawrence","Chopra, Teena","32441243"],"abstract":["We describe 9 patients at a medical center in Detroit, Michigan, USA, with severe acute respiratory syndrome coronavirus 2 and Clostridiodes difficile. Both infections can manifest as digestive symptoms and merit screening when assessing patients with diarrhea during the coronavirus disease pandemic. These co-infections also highlight the continued importance of antimicrobial stewardship."],"journal":"Emerg Infect Dis","authors":["Sandhu, Avnish","Tillotson, Glenn","Polistico, Jordan","Salimnia, Hossein","Cranis, Mara","Moshos, Judy","Cullen, Lori","Jabbo, Lavina","Diebel, Lawrence","Chopra, Teena"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441243","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3201/eid2609.202126","keywords":["covid-19","clostridiodes difficile","detroit","michigan","sars-cov-2","united states","antibiotics","antimicrobial drug resistance","bacteria","bacterial infections","co-infection","coronavirus disease","diarrhea","nosocomial infections","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Detroit","Michigan","USA","Clostridiodes","Detroit","Michigan","USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1667535119499395074,"score":9.490897,"similar":[{"pmid":32407284,"title":"Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.","text":["Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.","Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients.","Emerg Infect Dis","Ferguson, Jessica","Rosser, Joelle I","Quintero, Orlando","Scott, Jake","Subramanian, Aruna","Gumma, Mohammad","Rogers, Angela","Kappagoda, Shanthi","32407284"],"abstract":["Limited data are available on the clinical presentation and outcomes of coronavirus disease (COVID-19) patients in the United States hospitalized under normal-caseload or nonsurge conditions. We retrospectively studied 72 consecutive adult patients hospitalized with COVID-19 in 2 hospitals in the San Francisco Bay area, California, USA, during March 13-April 11, 2020. The death rate for all hospitalized COVID-19 patients was 8.3%, and median length of hospitalization was 7.5 days. Of the 21 (29% of total) intensive care unit patients, 3 (14.3% died); median length of intensive care unit stay was 12 days. Of the 72 patients, 43 (59.7%) had underlying cardiovascular disease and 19 (26.4%) had underlying pulmonary disease. In this study, death rates were lower than those reported from regions of the United States experiencing a high volume of COVID-19 patients."],"journal":"Emerg Infect Dis","authors":["Ferguson, Jessica","Rosser, Joelle I","Quintero, Orlando","Scott, Jake","Subramanian, Aruna","Gumma, Mohammad","Rogers, Angela","Kappagoda, Shanthi"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407284","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3201/eid2608.201776","keywords":["covid-19","california","coronavirus diseases","icu","sars-cov-2","united states","coronavirus disease","hospitalization","mortality","outcomes","pneumonia","respiratory diseases","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["United States","California","USA","United States","USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Treatment"],"weight":1,"_version_":1666802845303701505,"score":193.4129},{"pmid":32487282,"title":"Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.","text":["Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.","There are few detailed investigations of neurologic complications in severe acute respiratory syndrome coronavirus 2 infection. We describe 3 patients with laboratory-confirmed coronavirus disease who development of encephalopathy and encephalitis. Neuroimaging showed nonenhancing unilateral, bilateral, and midline changes not readily attributable to vascular causes. All 3 patients had increased cerebrospinal fluid (CSF) levels of anti-S1 IgM. One patient who died also had increased levels of anti-envelope protein IgM. CSF analysis also showed markedly increased levels of interleukin (IL)-6, IL-8, and IL-10, but severe acute respiratory syndrome coronavirus 2 was not identified in any CSF sample. These changes provide evidence of CSF periinfectious/postinfectious inflammatory changes during coronavirus disease with neurologic complications.","Emerg Infect Dis","Benameur, Karima","Agarwal, Ankita","Auld, Sara C","Butters, Matthew P","Webster, Andrew S","Ozturk, Tugba","Howell, J Christina","Bassit, Leda C","Velasquez, Alvaro","Schinazi, Raymond F","Mullins, Mark E","Hu, William T","32487282"],"abstract":["There are few detailed investigations of neurologic complications in severe acute respiratory syndrome coronavirus 2 infection. We describe 3 patients with laboratory-confirmed coronavirus disease who development of encephalopathy and encephalitis. Neuroimaging showed nonenhancing unilateral, bilateral, and midline changes not readily attributable to vascular causes. All 3 patients had increased cerebrospinal fluid (CSF) levels of anti-S1 IgM. One patient who died also had increased levels of anti-envelope protein IgM. CSF analysis also showed markedly increased levels of interleukin (IL)-6, IL-8, and IL-10, but severe acute respiratory syndrome coronavirus 2 was not identified in any CSF sample. These changes provide evidence of CSF periinfectious/postinfectious inflammatory changes during coronavirus disease with neurologic complications."],"journal":"Emerg Infect Dis","authors":["Benameur, Karima","Agarwal, Ankita","Auld, Sara C","Butters, Matthew P","Webster, Andrew S","Ozturk, Tugba","Howell, J Christina","Bassit, Leda C","Velasquez, Alvaro","Schinazi, Raymond F","Mullins, Mark E","Hu, William T"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487282","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3201/eid2609.202122","keywords":["atlanta","covid-19","csf","georgia","sars-cov-2","united states","cerebrospinal fluid","coronavirus disease","coronaviruses","cytokines","encephalitis","encephalopathy","meningitis/encephalitis","respiratory infections","serologic analysis","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Atlanta","Georgia","USA"],"countries":["United States","Georgia"],"countries_codes":["USA|United States","GEO|Georgia"],"topics":["Case Report"],"weight":1,"_version_":1668623433713319936,"score":186.84897},{"pmid":32491984,"title":"Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.","text":["Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.","We report the clinical features of 3 patients in France who had parotitis (inflammation of the parotid salivary glands) as a clinical manifestation of confirmed coronavirus disease. Results from magnetic resonance imaging support the occurrence of intraparotid lymphadenitis, leading to a parotitis-like clinical picture.","Emerg Infect Dis","Lechien, Jerome R","Chetrit, Annaelle","Chekkoury-Idrissi, Younes","Distinguin, Lea","Circiu, Marta","Saussez, Sven","Berradja, Najete","Edjlali, Myriam","Hans, Stephane","Carlier, Robert","32491984"],"abstract":["We report the clinical features of 3 patients in France who had parotitis (inflammation of the parotid salivary glands) as a clinical manifestation of confirmed coronavirus disease. Results from magnetic resonance imaging support the occurrence of intraparotid lymphadenitis, leading to a parotitis-like clinical picture."],"journal":"Emerg Infect Dis","authors":["Lechien, Jerome R","Chetrit, Annaelle","Chekkoury-Idrissi, Younes","Distinguin, Lea","Circiu, Marta","Saussez, Sven","Berradja, Najete","Edjlali, Myriam","Hans, Stephane","Carlier, Robert"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32491984","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3201/eid2609.202059","keywords":["covid-19","france","sars-cov-2","coronavirus disease","neck","node","parotid","parotitis","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["France","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Case Report"],"weight":1,"_version_":1668892169445834755,"score":157.83316},{"pmid":32160149,"title":"Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States.","text":["Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States.","The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States was given a diagnosis of infection with this virus by the state of Washington and the US Centers for Disease Control and Prevention on January 20, 2020. We isolated virus from nasopharyngeal and oropharyngeal specimens from this patient and characterized the viral sequence, replication properties, and cell culture tropism. We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin. We also deposited the virus into 2 virus repositories, making it broadly available to the public health and research communities. We hope that open access to this reagent will expedite development of medical countermeasures.","Emerg Infect Dis","Harcourt, Jennifer","Tamin, Azaibi","Lu, Xiaoyan","Kamili, Shifaq","Sakthivel, Senthil K","Murray, Janna","Queen, Krista","Tao, Ying","Paden, Clinton R","Zhang, Jing","Li, Yan","Uehara, Anna","Wang, Haibin","Goldsmith, Cynthia","Bullock, Hannah A","Wang, Lijuan","Whitaker, Brett","Lynch, Brian","Gautam, Rashi","Schindewolf, Craig","Lokugamage, Kumari G","Scharton, Dionna","Plante, Jessica A","Mirchandani, Divya","Widen, Steven G","Narayanan, Krishna","Makino, Shinji","Ksiazek, Thomas G","Plante, Kenneth S","Weaver, Scott C","Lindstrom, Stephen","Tong, Suxiang","Menachery, Vineet D","Thornburg, Natalie J","32160149"],"abstract":["The etiologic agent of an outbreak of pneumonia in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 in January 2020. A patient in the United States was given a diagnosis of infection with this virus by the state of Washington and the US Centers for Disease Control and Prevention on January 20, 2020. We isolated virus from nasopharyngeal and oropharyngeal specimens from this patient and characterized the viral sequence, replication properties, and cell culture tropism. We found that the virus replicates to high titer in Vero-CCL81 cells and Vero E6 cells in the absence of trypsin. We also deposited the virus into 2 virus repositories, making it broadly available to the public health and research communities. We hope that open access to this reagent will expedite development of medical countermeasures."],"journal":"Emerg Infect Dis","authors":["Harcourt, Jennifer","Tamin, Azaibi","Lu, Xiaoyan","Kamili, Shifaq","Sakthivel, Senthil K","Murray, Janna","Queen, Krista","Tao, Ying","Paden, Clinton R","Zhang, Jing","Li, Yan","Uehara, Anna","Wang, Haibin","Goldsmith, Cynthia","Bullock, Hannah A","Wang, Lijuan","Whitaker, Brett","Lynch, Brian","Gautam, Rashi","Schindewolf, Craig","Lokugamage, Kumari G","Scharton, Dionna","Plante, Jessica A","Mirchandani, Divya","Widen, Steven G","Narayanan, Krishna","Makino, Shinji","Ksiazek, Thomas G","Plante, Kenneth S","Weaver, Scott C","Lindstrom, Stephen","Tong, Suxiang","Menachery, Vineet D","Thornburg, Natalie J"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32160149","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200516","keywords":["2019 novel coronavirus disease","covid-19","pcr","sars-cov-2","united states","characterization","coronavirus","isolation","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Wuhan","China","United States","Washington","United States"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490658619392,"score":146.05687},{"pmid":32324118,"title":"Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.","text":["Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.","We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment.","Emerg Infect Dis","Adams, Mary L","Katz, David L","Grandpre, Joseph","32324118"],"abstract":["We estimated that 45.4% of US adults are at increased risk for complications from coronavirus disease because of cardiovascular disease, diabetes, respiratory disease, hypertension, or cancer. Rates increased by age, from 19.8% for persons 18-29 years of age to 80.7% for persons >80 years of age, and varied by state, race/ethnicity, health insurance status, and employment."],"journal":"Emerg Infect Dis","authors":["Adams, Mary L","Katz, David L","Grandpre, Joseph"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324118","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.200679","keywords":["covid-19","sars-cov-2","united states","chronic conditions","complications","coronavirus disease","infection","population-based estimates","respiratory infections","risk factors","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["US","Coronavirus Disease","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138493921787904,"score":143.88379}]}